Login to Your Account

Clinic Roundup

Wednesday, January 9, 2013

• Intercept Pharmaceuticals Inc., of New York, said partner Dainippon Sumitoma Pharma Co. Ltd., of Osaka, Japan, began a Phase II trial of obeticholic acid (OCA) in adult nonalcoholic steatohepatitis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription